Insider holders · CIK 0001498382
DelMar Pharmaceuticals, Inc. · DMPI
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| William J GarnerDirector | 2,415,207 | — | 2,415,207 | Jul 17, 2015 · 10:25 am EDT | Form 4 |
| Dennis M BrownChief Scientific Officer | 134,091 | 537,500 | 671,591 | Jan 2, 2019 · 6:16 pm EST | Form 4 |
| John K BellDirector | 74,737 | 96,429 | 171,166 | Jan 2, 2019 · 6:17 pm EST | Form 4 |
| Anthony Scott PraillChief Financial Officer | 73,421 | — | 73,421 | Jan 2, 2019 · 6:20 pm EST | Form 4 |
| Jeffrey BachaDirector | 64,049 | — | 64,049 | Apr 3, 2018 · 4:01 pm EDT | Form 4 |
| Saiid ZarrabianInterim CEO | 55,000 | 5,900 | 60,900 | Nov 16, 2017 · 4:30 pm EST | Form 4 |
| Robert Joseph Toth Jr.Director | 11,665 | — | 11,665 | Jan 2, 2019 · 6:21 pm EST | Form 4 |
| Erich MohrDirector | 8,222 | — | 8,222 | Apr 3, 2018 · 4:07 pm EDT | Form 4 |
| Lynda Sarah CranstonDirector | 0 | 2,841 | 2,841 | Jan 2, 2019 · 6:19 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.